Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne Benard-Slagter"'
Autor:
Esther H. Lips, Anne Benard-Slagter, Mark Opdam, Caroline E. Scheerman, Jelle Wesseling, Frans B. L. Hogervorst, Sabine C. Linn, Suvi Savola, Petra M. Nederlof
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-12 (2020)
Abstract Background We previously showed that BRCA-like profiles can be used to preselect individuals with the highest risk of carrying BRCA mutations but could also indicate which patients would benefit from double-strand break inducing chemotherapy
Externí odkaz:
https://doaj.org/article/80a0d3ee97954d7c860270878592b294
Autor:
Deepshi Thakral, Gurvinder Kaur, Ritu Gupta, Anne Benard-Slagter, Suvi Savola, Indresh Kumar, Rajni Anand, Lata Rani, Pramod Verma, Sangeeta Joshi, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Rachna Seth, Vivek Singh
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Recurrent clonal genetic alterations are the hallmark of Acute Lymphoblastic Leukemia (ALL) and govern the risk stratification, response to treatment and clinical outcome. In this retrospective study conducted on ALL patient samples, the purpose was
Externí odkaz:
https://doaj.org/article/386e97ecdc794f0fb771d29c56ec433a
Autor:
Péter Attila Király, Bálint Egyed, Donát Alpár, Karel de Groot, Henriett Pikó, Anne Benard-Slagter, László Pajor, András Matolcsy, Karoly Szuhai, Lajos Hegyi, Béla Kajtár, Suvi Savola, Csaba Bödör, Ágnes Vojcek, Richárd Kiss, Irén Haltrich, Ambrus Gángó, Gabor G. Kovacs, Szilvia Krizsán
Publikováno v:
Modern Pathology, 33(5), 812-824. SPRINGERNATURE
Acute lymphoblastic leukemia is the most common pediatric cancer characterized by a heterogeneous genomic landscape with copy number aberrations occurring at various stages of pathogenesis, disease progression, and treatment resistance. In this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f6dda924426e0042ef251d1a3e1c5d
http://hdl.handle.net/1887/3182628
http://hdl.handle.net/1887/3182628
Autor:
Lalit Kumar, Atul Sharma, Rajni Anand, Suvi Savola, Deepshi Thakral, Ritu Gupta, Pramod Verma, Vivek Singh, Sameer Bakhshi, Indresh Kumar, Rachna Seth, Sangeeta Joshi, Gurvinder Kaur, Anne Benard-Slagter, Lata Rani
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Recurrent clonal genetic alterations are the hallmark of Acute Lymphoblastic Leukemia (ALL) and govern the risk stratification, response to treatment and clinical outcome. In this retrospective study conducted on ALL patient samples, the purpose was
Autor:
Karoly Szuhai, Karel de Groot, Henriett Pikó, Donát Alpár, Péter Attila Király, Béla Kajtár, András Matolcsy, Szilvia Krizsán, László Pajor, Ágnes Vojcek, Csaba Bödör, Richárd Kiss, Suvi Savola, Lajos Hegyi, Gabor G. Kovacs, Irén Haltrich, Ambrus Gángó, Anne Benard-Slagter, Bálint Egyed
Publikováno v:
Blood. 134:1474-1474
Introduction: Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy characterized by a heterogeneous genomic landscape. Copy number aberrations (CNA) emerge during the development, progression and treatment resistance of ALL, and
Autor:
Christine J. Harrison, Ilse Zondervan, Farzaneh Ghazavi, Claire Schwab, Tim Lammens, Suvi Savola, Barbara De Moerloose, Karel de Groot, Jan P. Schouten, Sakari Knuutila, Pieter Van Vlierberghe, Anne Benard-Slagter, Virinder Kaur Sarhadi, Kim Vettenranta
Publikováno v:
JOURNAL OF MOLECULAR DIAGNOSTICS
Recurrent and clonal genetic alterations are characteristic of different subtypes of T- and B-cell lymphoblastic leukemia (ALL), and several subtypes are strong independent predictors of clinical outcome. A next-generation sequencing based multiplex